Global retail giant Walmart (NYSE:WMT) is expanding its blockchain expertise by joining blockchain-powered pharmaceutical consortium MediLedger, industry media outlet CoinDesk reports on June 3.
Walmart is reportedly planning to roll out a pilot project to track pharmaceutical products using MediLedger technology with the United States Food and Drug Administration in early June.
Continue Reading on Coin Telegraph